How to determine if a token is a security- the Howey TestFAQ
intend to raise significant amounts of capital from US investors- which ... Timeline Schedule for a Reg D STO ManhattanStreet-STO(TM) Program Services that we ...
You are here
Page not found
Search results
What’s Really Needed to Start a Business?Blog
misspelled e-mails and has incorrect information listed on its business cards. ... and more. He is an experienced investor who has built a Venture Capital ...
Rebrain.aiOffering
and investor. In his twenties, he founded and developed a company with $40 million in revenue in the digital advertising and marketing industry with an IPO ...
TransCode Therapeutics LeadershipOffering Pages
skills. He built extensive knowledge of the institutional investor and research analyst communities and has developed highly effective investor ... and Max‐Planck‐Institute of Development Biology, Germany. Alan Freidman Investor Relations ...
What Is a Qualified Institutional Buyer (QIB)?FAQ
Institutional Buyer (QIB) is an institutional investor and as a result, the SEC ... have put in place for Mainstreet investors. QIBs are institutional investors that own or manage at least $100 million worth of securities ...
SEC Improves Access to CapitalBlog
a Reg A+ capital raise. This will be most useful for OTCQB and OTCQX reporting companies because they can use Reg A+ to uplist or simply raise ...
Radiant Pain Relief CentresOffering
Highlights 91.4% of all patients complete at zero or near in pain score ... spend. Today, Radiant has been able to secure complete North American ... CPA An experienced and well respected CPA and long-time angel investor ...
Opu Labs Equity OfferingOffering
Bringing Trust to the $120 billion Skincare Industry
Is there any cost to investing on Manhattan Street Capital?FAQ
The offerings on Manhattan Street Capital are free for investors ... cases. Some companies choose to ask the investor to pay the debit card ... for the investor. It is made very clear during the investment process if you are being ...
IGF OncologyOffering
Develops targeted anti-cancer chemotherapy drugs with improved efficacy and lower side effects, currently in clinical trials at the Mayo Clinic.